As per available reports about 200 journals, 40 Conferences, 30 workshops are presently dedicated exclusively to medicine for osteoporosis and about 391 articles are being published on the current trends in medicine for osteoporosis. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to medicine for osteoporosis are being carried out. There are two categories of osteoporosis medications: antiresorptive medications that slow bone loss and anabolic drugs that increase the rate of bone formation. Bisphosphonates, calcitonin, denosumab, estrogen and estrogen agonists/antagonists are antiresorptive medicines, which will slow the bone loss that occurs in the breakdown part of the remodeling cycle. The goal of treatment with antiresorptive medicines is to prevent bone loss and lower the risk of breaking bones. Teriparatide, a form of parathyroid hormone, increases the rate of bone formation called anabolic drugs. The goal of treatment with teriparatide is to build bone and lower the risk of breaking bones.
|OMICS International hosts over 700 leading-edge peer reviewed Open Access Journals and organize over 1000 International Conferences annually all over the world. OMICS International journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities that ensure a rapid, quality and quick review process. OMICS International signed an agreement with more than 1000 International Societies to make healthcare information Open Access.|
List of major Orthopedics and related journals
List of major Orthopedics and related conferences
List of major Orthopedics and related research centres
|This page will be updated regularly.|
|This page was last updated on 18thSepÂ 2015|